N-cycloheptyl-2-(1-cyclohexylpiperidin-4-yl)-6,7-dimethoxyquinazolin-4-amine

ID: ALA515355

Chembl Id: CHEMBL515355

PubChem CID: 44561363

Max Phase: Preclinical

Molecular Formula: C28H42N4O2

Molecular Weight: 466.67

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2nc(C3CCN(C4CCCCC4)CC3)nc(NC3CCCCCC3)c2cc1OC

Standard InChI:  InChI=1S/C28H42N4O2/c1-33-25-18-23-24(19-26(25)34-2)30-27(31-28(23)29-21-10-6-3-4-7-11-21)20-14-16-32(17-15-20)22-12-8-5-9-13-22/h18-22H,3-17H2,1-2H3,(H,29,30,31)

Standard InChI Key:  VNWQKNOMXMZJHO-UHFFFAOYSA-N

Associated Targets(Human)

CCR4 Tclin C-C chemokine receptor type 4 (2819 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ccr4 C-C chemokine receptor type 4 (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 466.67Molecular Weight (Monoisotopic): 466.3308AlogP: 6.29#Rotatable Bonds: 6
Polar Surface Area: 59.51Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.89CX LogP: 5.97CX LogD: 3.51
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.50Np Likeness Score: -0.74

References

1. Yokoyama K, Ishikawa N, Igarashi S, Kawano N, Hattori K, Miyazaki T, Ogino S, Matsumoto Y, Takeuchi M, Ohta M..  (2008)  Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines.,  16  (14): [PMID:18539035] [10.1016/j.bmc.2008.05.036]

Source